Earnings GrowthAnalysts reiterate a buy rating due to upside risks in earnings and valuation, with targets set for higher earnings per share and valuation ratios.
Financial HealthA $500 million share buyback is planned, indicating confidence in the company's financial health and potential to return value to shareholders.
Market PerformanceSmith & Nephew shares have gained 35% year-to-date due to strong results in the first and second quarters, resilience to tariffs, and benefits from foreign exchange.